Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019;5(4):26-34.
doi: 10.18502/cmm.5.4.2062.

Species distribution and susceptibility profiles of Candida species isolated from vulvovaginal candidiasis, emergence of C. lusitaniae

Seyed Ebrahim Hashemi  1 , Tahereh Shokohi  2   3 , Mahdi Abastabar  2   3 , Narges Aslani  4 , Mahbobeh Ghadamzadeh  5 , Iman Haghani  3
Affiliations

Species distribution and susceptibility profiles of Candida species isolated from vulvovaginal candidiasis, emergence of C. lusitaniae

Seyed Ebrahim Hashemi et al. Curr Med Mycol. 2019.

Abstract

Background and purpose: The aim of the current study was to investigate the epidemiology of vulvovaginal candidiasis (VVC) and recurrent VVC (RVVC), as well as the antifungal susceptibility patterns of Candida species isolates.

Materials and methods: A cross-sectional study was carried out on 260 women suspected of VVC from February 2017 to January 2018. In order to identify Candida species isolated from the genital tracts, the isolates were subjected to polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) using enzymes Msp I and sequencing. Moreover, antifungal susceptibility testing was performed according to the Clinical and Laboratory Standards Institute guidelines (M27-A3).

Results: Out of 250 subjects, 75 (28.8%) patients were affected by VVC, out of whom 15 (20%) cases had RVVC. Among the Candida species, C. albicans was the most common species (42/95; 44.21%), followed by C. lusitaniae (18/95; 18.95%), C. parapsilosis (13/95; 13.69%), C. glabrata (8/95; 8.42%), C. kefyr (6/95; 6.31%), C. famata (5/95; 5.26%), C. africana (2/95; 2.11%), and C. orthopsilosis (1/95; 1.05%), respectively. Multiple Candida species were observed in 28% (21/75) of the patients. Nystatin showed the narrowest range of minimum inhibitory concentration (MIC) (0.25-16 μg/ml) against all Candida strains, whereas fluconazole (0.063-64 μg/ml) demonstrated the widest MIC range. In the current study, C. lusitaniae, as the second most common causative agent of VVC, was susceptible to all antifungal agents. Furthermore, 61.1% of C. lusitaniae isolates were inhibited at a concentration of ≤ 2 μg/ml, while 38.9% (n=7) of them exhibited fluconazole MICs above the epidemiologic cutoff values (ECV). Candida species showed the highest overall resistance against fluconazole (61.3%), followed by itraconazole (45.2%) and caspofungin (23.7%). All of C. albicans strains were resistant to itraconazole with a MIC value of ≥ 1 μg/ml; in addition, 87.5% of them were resistant to fluconazole. Moreover, 100% and 87.5% of C. glabrata strains were resistant to caspofungin and fluconazole, respectively.

Conclusion: As the findings revealed, the majority of VVC cases were caused by non-albicans Candida species which were often more resistant to antifungal agents. Candida lusitaniae generally had fluconazole MICs above the ECV. Given the propensity of C. lusitaniae to develop resistance under drug pressure, antifungals should be administered with caution. The emergence of these species justify the epidemiological surveillance surveys to watch out the distribution of yeast species.

Keywords: Antifungal susceptibility testing; C. lusitaniae; Candida species; PCR-RFLP; Vulvovaginal candidiasis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Polymerase chain reaction-restriction fragment length polymorphism assay (1.5% agarose gel electrophoresis) of ITS1-5.8S-ITS2 gene after restricting polymorphic region with MspI enzyme; lanes 1, 2, 4, and 5) C. parapsilosis, lane 3) C. glabrata, lanes 6, 8, and 12) C. famata, lanes 7 and 13) C. albicans, lanes 9 and 11) C. lusitaniae, lane 10) C. glabrata, and last lane) a 100-bp molecular ladder
Figure 2
Figure 2
Polymerase chain reaction amplification of HWP1 gene; lanes 1, 2, and 4) C. albicans, lane 3) C. africana, and lane M) a 100-bp molecular ladder
See this image and copyright information in PMC

References

    1. Richter SS, Galask RP, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J Clin Microbiol. 2005;43(5):2155–62. - PMC - PubMed
    1. Alizadeh M, Kolecka A, Boekhout T, Zarrinfar H, Ghanbari Nahzag MA, Badiee P, et al. Identification of Candida species isolated from vulvovaginitis using matrix assisted laser desorption ionization-time of flight mass spectrometry. Curr Med Mycol. 2017;3(4):21–5. - PMC - PubMed
    1. Vandeven AM, Emans S. Vulvovaginitis in the child and adolescent. Pediatr Rev. 1993;14(4):141–7. - PubMed
    1. Minooeianhaghighi MH, Sehatpour M, Shokri H. Determination of drug susceptibility of Candida strains isolated from patients with recurrent Candida vulvovaginitis and investigation of predisposing factors of the disease. Avicenna J Clin Med. 2017;23(4):336–44.
    1. Gonçalves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S. Vulvovaginal candidiasis: epidemiology, microbiology and risk factors. Crit Rev Microbiol. 2016;42(6):905–27. - PubMed

LinkOut - more resources